VIXOBEK

Serial Number 79333822
Registration 7014779
700

Registration Progress

Application Filed
Jan 13, 2022
Under Examination
Approved for Publication
Jan 17, 2023
Published for Opposition
Jan 17, 2023
Registered
Apr 4, 2023

Trademark Image

VIXOBEK

Basic Information

Serial Number
79333822
Registration Number
7014779
Filing Date
January 13, 2022
Registration Date
April 4, 2023
Published for Opposition
January 17, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 4, 2023
Registration
Registered
Classes
005

Rights Holder

Philogen S.p.A.

35
Address
La Lizza, 7
I-53100 Siena
IT

Ownership History

Philogen S.p.A.

Original Applicant
35
IT

Philogen S.p.A.

Owner at Publication
35
IT

Philogen S.p.A.

Original Registrant
35
IT

Legal Representation

Attorney
William Bak

USPTO Deadlines

Next Deadline
1364 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-04-04)
Due Date
April 04, 2029
Grace Period Ends
October 04, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description
Feb 21, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Aug 14, 2023 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 24, 2023 FIMP P FINAL DISPOSITION PROCESSED
Jul 24, 2023 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Jul 4, 2023 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 4, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER
Apr 4, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 25, 2023 GPNX P NOTIFICATION PROCESSED BY IB
Jan 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 17, 2023 PUBO A PUBLISHED FOR OPPOSITION
Jan 4, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 4, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 28, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 13, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 17, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 17, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 17, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 19, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 19, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 19, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 19, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 19, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 13, 2022 RFNT P REFUSAL PROCESSED BY IB
May 24, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 24, 2022 RFRR P REFUSAL PROCESSED BY MPU
Apr 16, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 15, 2022 CNRT R NON-FINAL ACTION WRITTEN
Apr 15, 2022 RFWR P NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Mar 12, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 11, 2022 CNRT R NON-FINAL ACTION WRITTEN
Feb 28, 2022 DOCK D ASSIGNED TO EXAMINER
Feb 22, 2022 MAFR O APPLICATION FILING RECEIPT MAILED
Feb 18, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 17, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 005
Biopharmaceutical preparations for the treatment of cancers; antibodies and antibody derivatives and fragments, namely, human monoclonal antibodies and their derivatives and fragments for medical use; biopharmaceutical preparations for the treatment of cancer of the brain and of soft tissue

Classification

International Classes
005